Advertisement News Archives - Page 1406 of 5245 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

November 16, 2026

FDA rejects Summit’s ivonescimab application for lung cancer

The US Food and Drug Administration (FDA) has declined to approve Summit Therapeutics’ biologics licence application (BLA) for ivonescimab in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).

FDA rejects Summit’s ivonescimab application for lung cancer